Menu
Not yet recruiting NCT07649551

Optimizing Implementation of Long Acting Injectable PrEP

No phase Interventional HIV Infections

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Plan-Do-Study-Act.
Who it may be relevant to
Registry conditions: HIV Infections. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available

Interventions

  • Behavioral Plan-Do-Study-Act
    Implementation strategy of conducting cyclical small tests of change using Plan-Do-Study-Act

Primary outcome measures

  • LAI-PrEP prescribing [Time frame: 3 months]

Eligibility criteria

Provider/staff inclusion criteria:

  • 18 years of age or older,
  • affiliated with a participating clinic, and
  • be involved in prescribing or supporting PrEP care delivery.

Provider/staff exclusion criteria:

  • 17 years of age or younger,
  • not affiliated with a participating clinic, and
  • not involved in prescribing or supporting PrEP care delivery.

De-identified electronic medical record review inclusion criteria:

  • 16 years of age or older, and
  • had a clinical visit for any form of PrEP care during the study period at a participating clinic site.

De-identified electronic medical record review exclusion criteria:

  • 15 years of age or younger, and
  • no clinical visit for any form of PrEP care during the study period at a participating clinic site.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Crossover
Masking
Open label
Primary purpose
Health services research

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07649551 · R34MH135746

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗